These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A hospital-based study of splenomegaly with special reference to the group of indeterminate origin. Sundaresan JB; Dutta TK; Badrinath S; Jagdish S; Basu D J Indian Med Assoc; 2008 Mar; 106(3):150, 152, 154 passim. PubMed ID: 18712133 [TBL] [Abstract][Full Text] [Related]
9. Imported malaria in adults in Auckland. Palmer CW; Ellis-Pegler RB N Z Med J; 1982 Dec; 95(721):849-52. PubMed ID: 6761610 [TBL] [Abstract][Full Text] [Related]
10. Atypical manifestations of Plasmodium vivax malaria. Mohapatra MK; Padhiary KN; Mishra DP; Sethy G Indian J Malariol; 2002; 39(1-2):18-25. PubMed ID: 14686106 [TBL] [Abstract][Full Text] [Related]
11. [Syndrome of tropical splenomegaly]. Al'pidovskiĭ VK Ter Arkh; 1982; 54(8):150-3. PubMed ID: 6753218 [No Abstract] [Full Text] [Related]
12. Tinospora cordifolia as an adjuvant drug in the treatment of hyper-reactive malarious splenomegaly--case reports. Singh RK J Vector Borne Dis; 2005 Mar; 42(1):36-8. PubMed ID: 15999460 [TBL] [Abstract][Full Text] [Related]
13. A case of hyper-reactive malarial splenomegaly. The role of rapid antigen-detecting and PCR-based tests. Mothe B; Lopez-Contreras J; Torres OH; Muñoz C; Domingo P; Gurgui M Infection; 2008 Mar; 36(2):167-9. PubMed ID: 17906843 [TBL] [Abstract][Full Text] [Related]
14. [Hyperreactive malarial splenomegaly: three clinical cases and literature review]. Camara B; Kantambadouno JB; Martin-Blondel G; Berry A; Alvarez M; Benoit-Vical F; Delmont J; Bouchaud O; Marchou B Med Mal Infect; 2009 Jan; 39(1):29-35. PubMed ID: 18952389 [TBL] [Abstract][Full Text] [Related]
15. The effect of short-term malaria chemoprophylaxis on the immune response of semi-immune adult volunteers. Lege-Oguntoye L; Onyemelukwe GC; Maiha BB; Udezue EO; Eckerbom S East Afr Med J; 1990 Nov; 67(11):770-8. PubMed ID: 2076677 [TBL] [Abstract][Full Text] [Related]
16. Hyper-reactive Malarial Splenomegaly (HMS) in malaria endemic area in Eastern Sudan. Allam MM; Alkadarou TA; Ahmed BG; Elkhair IS; Alansary EH; Ibrahim ME; Elhassan AM; Elhassan IM Acta Trop; 2008 Feb; 105(2):196-9. PubMed ID: 18023424 [TBL] [Abstract][Full Text] [Related]
17. [Molecular aspects of chloroquine and antifols resistance in P. falciparum]. Le Bras J; Durand R Ann Pharm Fr; 2001 Apr; 59(2):85-92. PubMed ID: 11320332 [TBL] [Abstract][Full Text] [Related]
18. Tropical splenomegaly syndrome: who gets oesophageal varices? el-Shazly MA; Okello DO East Afr Med J; 1994 Dec; 71(12):768-70. PubMed ID: 7705243 [TBL] [Abstract][Full Text] [Related]
19. Levels of malaria specific immunoglobulin G in Nigerian sickle cell disease patients with and without splenomegaly. Abjah UM; Aken'Ova YA Niger J Med; 2003; 12(1):32-8. PubMed ID: 12956005 [TBL] [Abstract][Full Text] [Related]
20. Haematological parameters in sickle cell anaemia patients with and without splenomegaly. Durosinmi MA; Salawu L; Ova YA; Lawal OO; Fadiran OA Niger Postgrad Med J; 2005 Dec; 12(4):271-4. PubMed ID: 16380738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]